Sequence variants of interleukin 6 (IL-6) are significantly associated with a decreased risk of late-onset Alzheimer's disease
Open Access
- 24 January 2012
- journal article
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 9 (1) , 21
Abstract
Background: Interleukin 6 (IL-6) has been related to beta-amyloid aggregation and the appearance of hyperphosphorylated tau in Alzheimer's disease (AD) brain. However, previous studies relating IL-6 genetic polymorphisms to AD included few and unrepresentative single nucleotide polymorphisms (SNPs) and the results were inconsistent. Methods: This is a case-control study. A total of 266 patients with AD, aged≧65, were recruited from three hospitals in Taiwan (2007-2010). Controls (n = 444) were recruited from routine health checkups and volunteers of the hospital during the same period of time. Three common IL-6 haplotype-tagging SNPs were selected to assess the association between IL-6 polymorphisms and the risk of late-onset AD (LOAD). Results: Variant carriers of IL-6 rs1800796 and rs1524107 were significantly associated with a reduced risk of LOAD [(GG + GC vs. CC): adjusted odds ratio (AOR) = 0.64 and (CC + CT vs. TT): AOR = 0.60, respectively]. Haplotype CAT was associated with a decreased risk of LOAD (0 and 1 copy vs. 2 copies: AOR = 0.65, 95% CI = 0.44-0.95). These associations remained significant in ApoE e4 non-carriers only. Hypertension significantly modified the association between rs2069837 polymorphisms and the risk of LOAD (p interaction = 0.03). Conclusions: IL-6 polymorphisms are associated with reduced risk of LOAD, especially in ApoE e4 non-carriers. This study identified genetic markers for predicting LOAD in ApoE e4 non-carriers.Keywords
This publication has 38 references indexed in Scilit:
- Alzheimer's DiseaseNew England Journal of Medicine, 2010
- Association between interleukin-6 gene promoter −572C/G polymorphism and the risk of sporadic Alzheimer’s diseaseNeurological Sciences, 2009
- Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer’s disease mouse models with abundant Aβ in plasmaNeurobiology of Disease, 2006
- A comprehensive association study for genes in inflammation pathway provides support for their roles in prostate cancer risk in the CAPS studyThe Prostate, 2006
- Polymorphisms in the interleukin 6 and transforming growth factor β1 gene and risk of dementiaNeuroscience Letters, 2006
- Sequence Variants of Toll-Like Receptor 4 and Susceptibility to Prostate CancerCancer Research, 2005
- Vascular Dementia Prevention: A Risk Factor AnalysisCerebrovascular Diseases, 2005
- An Interleukin-6 Promoter Variant Is Not Associated with an Increased Risk for Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 2004
- The Structure of Haplotype Blocks in the Human GenomeScience, 2002
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984